Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 464 across all filing types
Latest filing 2021-06-14 Declaration of Voting R…
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed disclosure of voting results from a meeting of equity shareholders convened by the National Company Law Tribunal (NCLT). It includes the Scrutinizer's Report on remote e-voting and e-voting at the meeting, pursuant to regulatory requirements under the Companies Act, SEBI regulations, and NCLT orders. The content focuses on the official results of shareholder votes on a specific resolution regarding a scheme of amalgamation. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a proxy solicitation or a management report but specifically the official voting results and the scrutinizer's report on the vote. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length and detail confirm it is the actual voting results report, not just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2021-06-14 English
Shareholders meeting
Board/Management Information Classification · 95% confidence The document is a detailed summary of the proceedings of a Court Convened Meeting (CCM) of equity shareholders of Lasa Supergenerics Limited. It includes the date, time, mode of the meeting, attendance, agenda, voting procedures, and the outcome of the meeting. The document references compliance with SEBI Listing Regulations and the Companies Act, 2013. It is not a full financial report, audit report, or earnings release. It is not a proxy solicitation or voting results declaration but rather a detailed meeting proceedings report. The document is longer than 5,000 characters and contains substantive content about the meeting itself, not just an announcement or a brief summary. Therefore, it fits best under the category of Board/Management Information (MANG), as it relates to shareholder meeting proceedings and company governance matters involving shareholders and court orders.
2021-06-13 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the launch of a new product, Oxyclozanide, by Lasa Supergenerics Limited. It includes details about the product, production plans, management comments, and company background. There are no financial statements, regulatory filings, voting results, or other formal report content. The document is a media release intended for public and investor information about a new product launch and capacity expansion. This fits the category of a Capital/Financing Update (CAP) as it relates to company expansion and product launch, which can impact capital and business operations. It is not an earnings release or annual report, nor is it a regulatory filing or management report. Therefore, the best classification is Capital/Financing Update (CAP).
2021-06-09 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the company's financial results for the fourth quarter and full fiscal year ended March 31, 2021. It includes key financial highlights such as revenue, EBITDA, PAT, EPS, and commentary from the chairman. The document is titled 'Media Release' and explicitly states it is a press release. It does not contain full financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The document is relatively short (5437 characters) and serves as an initial announcement of financial results, which aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER). FY 2021
2021-06-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an announcement dated June 1, 2021, informing about an upcoming earnings call scheduled for June 4, 2021, to discuss the audited financial results for the quarter and financial year ended March 31, 2021. It includes details for joining the conference call but does not contain any actual financial data or results. The document references the financial results but does not present them, indicating it is a notification of the earnings call rather than the call transcript or the earnings release itself. Given the content and length (3572 characters), it fits the category of a Call Transcript announcement or notification. However, since it is only an intimation of the earnings call and not the transcript, the best fitting category is Call Transcript (CT) as it relates directly to the earnings call event. Confidence is high due to clear mention of earnings call details and absence of financial data or transcript text.
2021-06-01 English
Financial Result Updates
Regulatory Filings
2021-05-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.